Skip to main content


  • Retraction Note
  • Open Access

Retraction Note: TGFβ1 activates c-Jun and Erk1 via aVβ6 integrin

Molecular Cancer20043:1

  • Received: 12 January 2004
  • Accepted: 14 January 2004
  • Published:

The original article was published in Molecular Cancer 2003 2:33

The data published in this article [1] and in a preceding article in Molecular Cancer [2] were generated by myself, the corresponding author, with collaborators in Germany. The data were originally part of a manuscript on which my collaborators were authors and which remains unpublished. When publishing the data in Molecular Cancer, I failed to obtain the agreement from my past collaborators or to acknowledge their contributions, resulting in an unfair representation of their ideas and thoughts. In light of this, I have decided to retract the two papers. I deeply apologize for any inconvenience this may have caused.


Authors’ Affiliations

Department of Dermatology, Weill Medical College of Cornell University, 1300 York Avenue, New York, New York 10021, USA
Department of Surgical Oncology and Molecular Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA


  1. Luettich K, Schmidt C: TGFβ1 activates c-Jun and Erk1 via aVβ6 integrin. Mol Cancer. 2003, 2: 33, 10.1186/1476-4598-2-33.PubMed CentralView ArticlePubMedGoogle Scholar
  2. Kracklauer MP, Schmidt C, Sclabas GM: TGFβ1 signaling via aVβ6 integrin. Mol Cancer. 2003, 2: 28, 10.1186/1476-4598-2-28.PubMed CentralView ArticlePubMedGoogle Scholar


© Luettich and Schmidt; licensee BioMed Central Ltd. 2004

This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.